Biceph-Net: A robust and lightweight framework for the diagnosis of Alzheimer's disease using 2D-MRI scans and deep similarity learning

• URL: http://arxiv.org/abs/2203.12197v1
• Date: Wed, 23 Mar 2022 05:14:50 GMT
• Title: Biceph-Net: A robust and lightweight framework for the diagnosis of Alzheimer's disease using 2D-MRI scans and deep similarity learning
• Authors: A. H. Rashid, A. Gupta, J. Gupta, M. Tanveer
• Abstract summary: Alzheimer's Disease (AD) is a neurodegenerative disease that is one of the significant causes of death in the elderly population. Deep learning techniques have been proposed to diagnose AD using Magnetic Resonance Imaging (MRI) scans. We propose a novel and lightweight framework termed 'Biceph-Net' for AD diagnosis using 2D MRI scans.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Alzheimer's Disease (AD) is a neurodegenerative disease that is one of the significant causes of death in the elderly population. Many deep learning techniques have been proposed to diagnose AD using Magnetic Resonance Imaging (MRI) scans. Predicting AD using 2D slices extracted from 3D MRI scans is challenging as the inter-slice information gets lost. To this end, we propose a novel and lightweight framework termed 'Biceph-Net' for AD diagnosis using 2D MRI scans that model both the intra-slice and inter-slice information. Biceph-Net has been experimentally shown to perform similar to other Spatio-temporal neural networks while being computationally more efficient. Biceph-Net is also superior in performance compared to vanilla 2D convolutional neural networks (CNN) for AD diagnosis using 2D MRI slices. Biceph-Net also has an inbuilt neighbourhood-based model interpretation feature that can be exploited to understand the classification decision taken by the network. Biceph-Net experimentally achieves a test accuracy of 100% in the classification of Cognitively Normal (CN) vs AD, 98.16% for Mild Cognitive Impairment (MCI) vs AD, and 97.80% for CN vs MCI vs AD.

Related papers

• Hierarchical Graph Convolutional Network Built by Multiscale Atlases for Brain Disorder Diagnosis Using Functional Connectivity [48.75665245214903]
  We propose a novel framework to perform multiscale FCN analysis for brain disorder diagnosis. We first use a set of well-defined multiscale atlases to compute multiscale FCNs. Then, we utilize biologically meaningful brain hierarchical relationships among the regions in multiscale atlases to perform nodal pooling.
  arXiv  Detail & Related papers  (2022-09-22T04:17:57Z)
• Is a PET all you need? A multi-modal study for Alzheimer's disease using 3D CNNs [3.678164468512092]
  Alzheimer's Disease (AD) is the most common form of dementia and often difficult to diagnose due to the multifactorial etiology of dementia. Recent works on neuroimaging-based computer-aided diagnosis with deep neural networks (DNNs) showed that fusing structural magnetic resonance images (sMRI) and fluorodeoxyglucose positron emission tomography (FDG-PET) leads to improved accuracy in a study population of healthy controls and subjects with AD. We argue that future work on multi-modal fusion should systematically assess the contribution of individual modalities following our proposed evaluation framework.
  arXiv  Detail & Related papers  (2022-07-05T14:55:56Z)
• CNN-based fully automatic wrist cartilage volume quantification in MR Image [55.41644538483948]
  The U-net convolutional neural network with additional attention layers provides the best wrist cartilage segmentation performance. The error of cartilage volume measurement should be assessed independently using a non-MRI method.
  arXiv  Detail & Related papers  (2022-06-22T14:19:06Z)
• 3-Dimensional Deep Learning with Spatial Erasing for Unsupervised Anomaly Segmentation in Brain MRI [55.97060983868787]
  We investigate whether using increased spatial context by using MRI volumes combined with spatial erasing leads to improved unsupervised anomaly segmentation performance. We compare 2D variational autoencoder (VAE) to their 3D counterpart, propose 3D input erasing, and systemically study the impact of the data set size on the performance. Our best performing 3D VAE with input erasing leads to an average DICE score of 31.40% compared to 25.76% for the 2D VAE.
  arXiv  Detail & Related papers  (2021-09-14T09:17:27Z)
• Brain Age Estimation From MRI Using Cascade Networks with Ranking Loss [75.03117866578913]
  A novel 3D convolutional network, called two-stage-age-network (TSAN), is proposed to estimate brain age from T1-weighted MRI data. Experiments with $6586$ MRIs showed that TSAN could provide accurate brain age estimation.
  arXiv  Detail & Related papers  (2021-06-06T07:11:25Z)
• DFENet: A Novel Dimension Fusion Edge Guided Network for Brain MRI Segmentation [0.0]
  We propose a novel Dimension Fusion Edge-guided network (DFENet) that can meet both of these requirements by fusing the features of 2D and 3D CNNs. The proposed model is robust, accurate, superior to the existing methods, and can be relied upon for biomedical applications.
  arXiv  Detail & Related papers  (2021-05-17T15:43:59Z)
• 3D Convolutional Neural Networks for Stalled Brain Capillary Detection [72.21315180830733]
  Brain vasculature dysfunctions such as stalled blood flow in cerebral capillaries are associated with cognitive decline and pathogenesis in Alzheimer's disease. Here, we describe a deep learning-based approach for automatic detection of stalled capillaries in brain images based on 3D convolutional neural networks. In this setting, our approach outperformed other methods and demonstrated state-of-the-art results, achieving 0.85 Matthews correlation coefficient, 85% sensitivity, and 99.3% specificity.
  arXiv  Detail & Related papers  (2021-04-04T20:30:14Z)
• Deep Convolutional Neural Network based Classification of Alzheimer's Disease using MRI data [8.609787905151563]
  Alzheimer's disease (AD) is a progressive and incurable neurodegenerative disease which destroys brain cells and causes loss to patient's memory. In this paper, we have proposed a smart and accurate way of diagnosing AD based on a two-dimensional deep convolutional neural network (2D-DCNN) using imbalanced three-dimensional MRI dataset. The model classifies MRI into three categories: AD, mild cognitive impairment, and normal control: and has achieved 99.89% classification accuracy with imbalanced classes.
  arXiv  Detail & Related papers  (2021-01-08T06:51:08Z)
• Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: Evaluation in Alzheimer's disease [0.8031935951075242]
  Convolutional neural networks (CNN) achieve high diagnostic accuracy for detecting Alzheimer's disease (AD) dementia based on magnetic resonance imaging (MRI) scans. One important reason for this is a lack of model comprehensibility. We investigated whether models with higher accuracy also rely more on discriminative brain regions predefined by prior knowledge.
  arXiv  Detail & Related papers  (2020-12-18T15:16:50Z)
• Fader Networks for domain adaptation on fMRI: ABIDE-II study [68.5481471934606]
  We use 3D convolutional autoencoders to build the domain irrelevant latent space image representation and demonstrate this method to outperform existing approaches on ABIDE data.
  arXiv  Detail & Related papers  (2020-10-14T16:50:50Z)
• Explainable Deep CNNs for MRI-Based Diagnosis of Alzheimer's Disease [3.3948742816399693]
  Deep Convolutional Neural Networks (CNNs) are becoming prominent models for semi-automated diagnosis of Alzheimer's Disease (AD) using brain Magnetic Resonance Imaging (MRI) We propose an alternative explanation method that is specifically designed for the brain scan task. Our method, which we refer to as Swap Test, produces heatmaps that depict the areas of the brain that are most indicative of AD, providing interpretability for the model's decisions in a format understandable to clinicians.
  arXiv  Detail & Related papers  (2020-04-25T18:14:49Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.